[Glucocorticoid therapy in collagen diseases diseases]

scientific article published on 01 April 2005

[Glucocorticoid therapy in collagen diseases diseases] is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1052072204
P356DOI10.1007/S00393-005-0721-9
P698PubMed publication ID15868333

P2093author name stringM Kayser
L Unger
K Manger
H Nüsslein
M Enderlein
P2860cites workFactors associated with coronary artery calcification in young female patients with SLE.Q33188178
Refractory immune thrombocytopenia in systemic lupus erythematosus: response to mycophenolate mofetilQ33349723
Premature atherosclerosis in systemic lupus erythematosusQ33893354
Epidemiology of cardiovascular disease in systemic lupus erythematosusQ33915424
Systemic lupus erythematosus: a model for atherogenesis?Q33922220
Interstitial lung disease in systemic lupus erythematosusQ34013368
Treatment of lupus with corticosteroidsQ34226968
Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosusQ34398069
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysisQ34961416
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatologyQ35551818
Lupus nephritis: current issuesQ35553102
The ACR nomenclature for CNS lupus revisited.Q35625216
Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosusQ35625220
Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trialsQ35642238
Systemic lupus erythematosus trials: successes and issuesQ35864660
Cerebral inflammation and degeneration in systemic lupus erythematosusQ35864676
Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of actionQ35941069
Criteria for steroid-sparing ability of interventions in systemic lupus erythematosus: report of a consensus meetingQ35941075
Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.Q42166619
Evaluation of the effects of methylprednisolone pulse therapy in patients with systemic lupus erythematosus with brain involvement by Tc-99m HMPAO brain SPECT.Q44685474
Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone densityQ45013118
Mortality and causes of death in systemic lupus erythematosus.Q45986924
Pattern of neuropsychologic dysfunction in inactive systemic lupus erythematosusQ48599424
Predicting infection in hospitalized patients with systemic lupus erythematosusQ71732178
Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluationQ73115074
Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spineQ73807073
Damage in systemic lupus erythematosus and its association with corticosteroidsQ74175875
A new hypothesis of modular glucocorticoid actions: steroid treatment of rheumatic diseases revisitedQ74552357
Systemic lupus erythematosus and acute pancreatitis: a case seriesQ79827674
Biomarkers, surrogate markers, and design of clinical trials of new therapies for systemic lupus erythematosusQ80502363
P433issue3
P1104number of pages8
P304page(s)162-169
P577publication date2005-04-01
P1433published inZeitschrift fuer RheumatologieQ15763293
P1476title[Glucocorticoid therapy in collagen diseases diseases]
P478volume64

Reverse relations

Q34648235A comparative effectiveness study of bone density changes in women over 40 following three bone health plans containing variations of the same novel plant-sourced calciumcites workP2860

Search more.